Partnership Opportunities

Partner with us to:

Raise Brand Awareness

Benefit from pre- and post-conference exposure to our community of decision-makers through unique branding formats and interviews

Position Yourself as an Industry Expert

Be part of this growing field at the leading industry forum

Virtually Meet and Network with Industry Pioneers

Gain meaningful connections pre, during, and post-conference with bespoke 1-2-1 meetings

Generate Commercial Collaborations

Educate the industry on your solution, product, or platform with a dedicated booth

Why TGF-β?

Building on the success of anti-PD-1, PD-L1, and anti-CTLA4 therapies, TGF-β is continuing to show promise to drug developers as the next blockbuster checkpoint combination for novel immuno-oncology treatment.

The innovators developing these therapeutics are looking for new solutions in the following areas:

  • Advanced Preclinical & Translational Models
  • Clinical Research
  • Biomarker Identification & Patient Selection
  • Cell-Based Assays
  • Single Cell Sequencing & Analytics
  • Toxicology & PKPD Screening
TGFb for Immuno-Oncology Drug Development infographic

Past Attendees Included:

Homepage Attending Companies Image

View a Demo of the Digital Platform